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Abstract: TlllllOur suppressor genes are a class of genes that have a crucial role in the genesis of neoplasia. 
These genes when transcribed and translated, result in the production of proteins that regulate the cell cycle, 
repair any DNA mutations and control apoptosis. When tumour suppressor genes are mutated, cells lose 
control and this leads to neoplastic growth. A good analogy is comparing a tumour suppressor gene with the 
brake pedal of a car. The tlllllOur suppressor gene prevents the cell from dividing too quickly just as a brake 
keeps the car from going too fast. 
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INTRODUCTION 
Identification of the genes that are mutated in the 
genesis of neoplasia is mandatory. Its only when one 
llllderstands the aetiology of a disease that prevention 
and the best treatment can be provided. The two main 
classes of genes that have been implicated in the 
pathogenesis of neoplasia are the tlllllOur suppressor 
genes and the oncogenes. The oncogenes were initially 
identified as genes in the viral DNA that cause 
transformation of their target cells. However, a major class 
of viral oncogenes have cellular cOllllterparts that are 
involved in normal cell fllllction. These cellular genes are 
called proto-oncogenes and when mutated they are 
known as oncogenes. The converSIOn of proto 
oncogenes into oncogenes portrays an example of gain 
of function mutation (Mueller and Young, 2002). The 
products of these proto-oncogenes are crucial for the 
ordered progression through the cell cycle. Their vital role 
is reflected in the fact that they have been highly 
conserved throughout evolution. The mechanisms that 
are involved in the activation of the proto-oncogenes into 
oncogenes are varIOUS. These include either point 
mutations in the proto-onocgene or else a duplication that 
results in multiple copies of the same gene or else a 
translocation. Contrary to the tumour suppressor genes, 
mutation in only one of the alleles is enough to induce 
neoplastic growth (Lodish, 2000). The second class of 
genes that are involved in neoplasia formation are the 
tlllllOur suppressor genes. The role of the tlllllOur 
suppressor genes in tlllllOur formation was originally 
proposed in the 1960's when it was suggested that some 
forms of hereditary cancer might be initiated when a cell 
in a person heterozygous for a germ line mutation 
lllldergoes a second somatic mutation. This renders the 
cell homozygous for loss of fllllction mutations III a 
tlllllOur suppressor gene and this gives rise to a tlllllOur. 
This is known as Knudson's two hit model of 
tlllllorigenesis. This is now widely accepted as the 
basis for both the hereditary and sporadic cancers 
(Gelehrter e/ aI., 2000). 
Although, both the tlllllOur suppressor genes as well 
as the proto-oncogenes are crucial in determining the 
onset of cancer, genes do not act in vaCUlllll but the 
action of a particular type of gene is highly dependent on 
the whole set of the other slllTollllding genes that 
constitute the genetic backgrolllld. Also one has to keep 
in mind that neoplasia is a complex process. Genetic, 
environmental, dietary and microbial factors are all closely 
intertwined with one another and all have a role to play in 
neoplasia. 
TUMOUR SUPPRESSOR GENES AND 
THEm ROLE IN NEOPLASIA 
The tlllllOur suppressor genes as their name implies 
are a class of genes that regulate cell proliferation. Various 
types of tlllllOur suppressor genes exit which can e widely 
classified into, genes that control cell division, genes that 
repair DNA and cell suicide genes (Lodish, 2000). 
GENES THAT CONTROL CELL DIVISION 
Some tlllllOur suppressor genes help control cell 
growth and division. The Retinoblastoma gene (RBI) 
gene is an example of such a gene. Abnormalities of the 
RBI gene can lead to retinoblastoma which is a type of 
eye malignancy in infants, as well as to other cancers. 
Because all the chromosomes are paired, there are always 
two copies of each gene. The inherited RBI mutation only 
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effects one of the genes. Since the person has one 
good gene and a mutated one, its said that the person is 
heterozygous for the trait (Tomlinson el al.. 2001). In this 
situation, the person does not develop the disease. Then 
during the infant's development, a random mutation can 
occur in the normal copy of the RBI gene. This process is 
known as loss of heterozygosity. "When both genes are 
mutated, llllcontrolled cell proliferation occurs as the 
products of some tumour suppressor genes like 
retinoblastoma and p53 restrict cells at the G l-S phase of 
the cell cycle preventing their entry into the proliferative 
phase of the cell cycle (Lodish, 2000). 
GENES THAT REPAIR DNA 
A second group of tlllllOur suppressor genes IS 
responsible for repairing DNA damage. Every time a cell 
prepares to divide, it must first duplicate its DNA. This 
process is not perfect and copying errors sometimes 
occur. Fortrnmtely, cells have DNA repair genes which 
code for proteins that proofread DNA. But if the genes 
responsible for the repair are mutated, then the DNA can 
develop abnormalities that go ullllOticed and thus 
unrepaired (Mueller and Young. 2002). The mutations 
responsible for Hl'.JPCC (Hereditary non polyposis colon 
cancer) are an example of DNA repair gene defects. 
Although, DNA repair enzymes do not directly fllllction 
to inhibit cell proliferation, cells that have lost the 
ability to repair errors, gaps or broken ends in DNA 
accwnulate mutations in many genes, including those that 
are critical in controlling cell growth and proliferation. 
Thus loss of fllllction mutations in the genes encoding 
DNA repair enzymes promote inactivation of other tumour 
suppressor genes as well as activation of oncogenes 
(Lodish.2000). 
CELL SUICIDE GENES 
If there is too much damage to a cell's DNA that can't 
be fixed by the DNA repair genes. the p53 tumour 
suppressor gene is responsible for destroying the cell by 
triggering apoptosis. If the p53 gene is mutated, cells with 
DNA damage that have not been repaired continue to 
grow and proliferate and can eventually become 
cancerous (Lewin, 2000). Abnormalities of the p53 gene 
are sometimes inherited such as in the Li Frawneni 
Syndrome (LFS). People with LFS have a higher risk of 
developing a nwnber of malignancies including soft tissue 
and bone sarcomas, brain tumours, breast cancer, adrenal 
gland cancer and leukemia. Many sporadic cancers such 
as hmg, colon and breast also develop following a 
mutation in the p53 gene (Collins elal .• 1997). 
Twnour suppressor genes like p53 and p21 are also 
called anti oncogenes. They were first given this name 
because they reverse at least in cell culture the action of 
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known oncogenes. The main important difference 
between oncogenes and twnour suppressor genes is that 
the onocgnes result from the activation of proto 
oncogenes but twnour suppressor genes lead to 
neoplasia when they are inactivated. Another major 
difference between the two is that while the overwhelming 
majority of oncogenes develop from sporadic mutations 
of the proto oncogenes during the life of the individual 
(acquired mutations), abnormalities of the tumour 
suppressor genes can be inherited as well as acquired 
(Gelehrter el al.. 2000). In the following discussion. I will 
be considering mainly the role of tumour suppressor 
genes in neoplasia. However, one need to bear in mind 
that both the tumour suppressor genes as well as the 
protooncogenes are crucial in determining the onset of 
cancer. Genes do not act in a vacuwn but the action of a 
particular type of gene highly depends on the whole set 
of the other sWTollllding genes that constitute the genetic 
backgrolllld. The importance of twnour suppressor gene 
mutations and their link to cancer was originally proposed 
in the 1960s. It was suggested that some forms of 
hereditary cancer might be initiated when a cell in a 
person heterozygous for a germ line mutation lllldergoes 
a second somatic mutation thus rendering the cell 
homozygous for loss of fllllction mutations in a tumour 
suppressor genes. This leads to llllcontrolled proliferation 
and twnour formation (Tomlinson et aI., 2001). 
Loss of both alleles of a twnour suppressor gene also 
plays an important part in the pathogenesis of many 
common sporadic cancers. In this instance however, both 
alleles are inactivated by two somatic events occWTing in 
the same cell. This two hit hypothesis was first applied for 
cancers that can occur both in the hereditary and sporadic 
forms such as retinoblastoma. But now the two hit 
hypothesis has been widely accepted as an important 
model in familial cancers including familial polyposis coli, 
familial breast cancer, neurofibromatosis type 1 (NF 1), 
colon carcinoma and the rare form of familial cancer 
known as lei frawneni syndrome (Lodish, 2000). 
Although, in each of these disorders autosomal dominant 
inheritance of one mutated gene is generally the rule, loss 
of fllllction of both copies of the responsible tumour 
suppressor gene is required for tumour development. The 
explanation of this seeming paradox is that cells 
heterozygous for a mutation still have a single fllllctional 
copy of twnour suppressor gene which is enough to 
prevent abnormal cellular phenotype. However, a cell 
which already has one copy of the tumour suppressor 
gene which is altered or lost by inheritance of germline 
mutation will lose its ability to suppress tumour 
development if by chance it loses fllllction of the other 
remaining allele. This second hit which is needed for the 
development of the twnour most often occurs as a result 
of a mutation but loss of fllllction without a mutation such 
as occurs with transcriptional silencing has also been 
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observed in some cancer cells (Nordling, 1953). Since the 
development of the sporadic tlllllOfS involves two 
separate somatic events, with the second hit having to 
occur in the same cell lineage that has experienced the 
first or predisposing hit, sporadic tlllllOfS are relatively 
rare and occur later on in life. They also have the 
additional features of being mrifocal and llllilateral. 
This contrasts with the hereditary tumours which 
occur at a YOllllger age and tend to be multifocal 
(Tomlinson e/ al.. 2001). The two hit model is now widely 
accepted as the basis for both the hereditary and 
sporadic cancers. As explained previously the theory had 
to be expanded recently when it was discovered that a 
second hit in the normal allele is not always necessarily a 
mutation as it was initially thought. Silencing due to 
excessive DNA methylation associated with a loss of 
accessibility of the DNA to the transcription factors has 
been fOlllld to be an important alternative molecular 
mechanism for loss of fllllction of a tumour suppressor 
gene (Nordling. 1953). 
MECHANISMS INVOLVED IN LOSS 
OF HETEROZYGOSITY 
Most studies that were done that confirmed the 
concept of loss of heterozygosity involved analysis of the 
DNA sequences in the region of the chromosome 13 in 
the peripheral blood as well as analysis of the 
retinoblastoma tumour material of children who had 
inherited the gene for retinoblastoma. These studies 
showed that children who developed retinoblastoma have 
a loss of an allele at the retinoblastoma locus in the 
twnour material. This is kno"\iVll as the Loss Of the 
Constitutioml Heterozygosity (LOCH) (Mueller and 
Y Olmg, 2002). So in a somatic cell that contains one 
mutant and one normal allele of a twnour suppressor 
gene, how is the normal allele lost or inactivated? Point 
mutations are an wliikely cause because mutations of this 
type are usually repaired except in cells that have 
defective DNA repair mechimisms (Harvey e/ al .• 1993). 
Loss of heterozygosity is better explained by missegre-
gation of the chromosomes bearing the heterozygous 
twnour suppressor gene during mitosis. In this process 
which is also referred to as non disjllllction, one daughter 
cell inherits only one normal chromosome (and probably 
dies) while the other inherits three chromosomes (the 
other normal chromosome as well as two bearing the 
mutant allele). Such missegregation is caused by failure of 
a mitotic checkpoint which would normally prevent a 
metaphase cell with an abnormal mitotic spindle from 
completing mitosis. Subsequent loss of one chromosome 
often occurs, restoring the 2n complement. If the normal 
chromosome is lost, the resultant cell will contain two 
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copies of the mutant chromosome (Mueller and Y Olmg, 
2002). Loss of heterozygosity can be caused by still other 
mechanisms which include a deletion of the chromosome 
carrying the corresponding allele or a cross over between 
the two homologous genes leading to homozygosity for 
the mutant allele. 
TYPES OF TUMOUR SUPPRESSOR GENES 
After having considered in detail what are tumour 
suppressor genes and their fllllction its important to deal 
with the different types of tumour suppressor genes that 
have been discovered. These include DCC, NFl, NF2, 
VHL. MLHl MSH2. MTSI. MTS2 and p53 tumour 
suppressor genes (Harvey e/ al.. 1993). The DCC gene in 
the 18q region contains a putative twnour suppressor 
gene. DCC (deleted in colon carcinoma. l8q2l). Allelic 
loss of chromosome 18, together with 17q, occurs in 70% 
of colorectal carcinomas with high frequency in ovarian 
adenocarcinomas (Turley e/ al.. 1995). The DCC 
protein is homologous to neural crest adhesion molecules 
(N-CAJ\.1). Its allelic loss or reduced expression is detected 
in colorectal, gastric, esophageal, pancreatic, breast, 
haematological and glial malignancies. Loss of DCC gene 
is associated with alterations in cellular attachment. The 
DCC gene encodes for a membrane bOlllld protein 
belonging to the immllllogiobulin superfamily. 
Abnormalities of the DCC twnour suppressor gene and 
abolished DCC fllllction may be critically involved in the 
development of gastric cancer. Recent studies fOlllld that 
the DCC gene product induces apoptosis by activating 
caspase-3. So, DCC may fllllction as a twnour 
suppressor gene which controls programmed cell death 
(Turley e/ al.. 1995). 
The MLHl MSH2 (Hereditary Non Polyposis Colon 
Cancer (Hl'.JPCC» gene is defective in colon cancer. Its 
carried in approximately 1 1200 individuals and its 
responsible for about 15% of all colon cancers. Two 
HNPCC genes loci have been detected, MSH2 and MLHl. 
The MSH2 gene is located on chromosome 2p22-21. It 
encodes a member of the MutS mismatch repair protein 
superfamily that binds to mismatched nucleotides in 
DNA. So they are able to prevent mutations during 
DNA replication. HJ.\JPCC patients show germline mutation 
in MSH2 at intronic splice acceptor site which is 
preswned to cause aberrant mRNA processmg 
(Bronner et aI., 1994). The VHL gene is the gene involve 
in von hippel landau disease which is a dominantly 
inherited familial cancer syndrome. VHL is located on 
chromosome 3p25-26 and it encodes a polypeptide of 28 
kDa. The cellular location of the product is the plasma 
membrane. The protein fllllction is not certain but the 
repeated acidic domain may contribute to VHL 
involvement in signal transduction or cell cell contacts 
(Pulhnan and Bodmer. 1992). One of the most important 
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twnour suppressor genes is p53. The p53 has been 
mapped to chromosome 17. In the cell p53 protein binds 
DNA. It recognises a 10 bp motif. Upon binding it 
stimulates another gene to produce a protein called p21 
that interacts with a cell division-stimulating protein 
(cdk2). When p21 is complexed with cdk2 the cell cannot 
pass through to the next stage of cell division 
(Greenblat et al .• 1994). Mutant p53 can no longer bind 
DNA in an effective way and as a consequence the p21 
protein is not made available to act as the stop signal for 
cell division. 
So the cells divide llllcontrollably and fonn tumours. 
Although, as was previously described, tlllllOur 
suppressor genes are generally viewed as being recessive 
at the cellular level so that mutation or loss of both 
twnour suppressor genes is a prerequisite for tumour 
formation, only one hit is needed for p53 to become 
twnorigenic. Since inactivation of one of the two 
suppressor loci can produce what appears to be a 
dominant effect, its said that p53 shows a dominant 
negative effect (Nigro, 1989). Two promoters have been 
demonstrated at the 5 prime end of the hwnan p53 gene. 
The first is located upstream of the first exon and is 
responsible for the transcription of the major p53 mRNA 
species. The second promoter is stronger than the first 
and is located approximately 1,000 base pairs dO"\iVllstream 
of exon 4 (Clarke et al .• 1993). These two promoters are the 
regulatory sites of the p53 gene. 
If the regulatory protein p53 is activated by protein 
kinases, ATM and ATR (these kinases detect damaged 
DNA). it activates a CDK inbibitor. p21 (Collins et al .• 
1997). This CDK inhibitor. p21 can bind to and inhibit the 
cyclin E-CDK2. preventing phosphorylation of the 
retinoblastoma protein. Unphosphorylated retinoblastoma 
protein binds to and inactivates E2F blocking passage 
from Gl-S (Clarke etal.. 1993). 
p53 AND ITS ROLE IN APOPTOSIS 
The wild type p53 can interact with the TATA 
binding protein directly and interfere with the initiation of 
transcription. p53 exerts its twnour suppressor activity by 
down regulating genes governing proliferation and up 
regulating genes involved in preventing growth. p53 
fllllctions to delay transit from the G 1 to S phase of the 
cell cycle. By delaying the transit time from the G 1 to the 
S phase of the cell cycle and hence the onset of mitosis, 
p53 reduces the likelihood of incorporating mutated DNA 
in the next generation. If however DNA is so damaged 
that repair C31lllot take place, the cells lllldergo a p53 
assisted process of cell death knO"\iVll as apoptosis. The 
latter is a specialised form of programmed cell death which 
leads to the elimination of the cells without releasing 
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harmful substances in the surrollllding area. Its 
characterised by chromosomal DNA fragmentation and 
cellular dissolution. 
p53 can mediate apoptosis by various mechanisms, 
one of which is mediated by a subfamily of cysteine 
proteases known as caspases (Greenblat et al., 1994). In 
mammalian cells, a major caspase activation pathway is 
the cytochrome c initiated pathway. In this pathway, a 
variety of apoptotic stimuli cause cytochrome c release 
from the mitochondria which in twn induces a series of 
biochemical reactions that result in caspase activation and 
subsequent cell death. Anti apoptotic genes like Bcl-2 and 
proapoptotic genes like Bax regulate release of 
cytochrome c. Bax also contains the p53 binding sites in 
its promoter site and is upregulated in response to DNA 
damage and increased p53 (Clarke et al.. 1993). 
Another mechanism by which p53 can mediate 
apoptosis is through the generation of Reactive Oxygen 
Species (ROS). The tumour suppressor protein p53 is a 
redox-active transcription factor that organises and 
directs cellular responses in the face of a variety of 
stresses that lead to genomic instability. Reactive Oxygen 
Species (ROS). generated by cells as products or by 
products, can fllllction either as signalling molecule or as 
cellular toxicants. Cellular generation ofROS is central to 
redox signalling. Studies have revealed that each cellular 
concentration and distribution of p53 has a distinct 
cellular fllllction and that ROS act as both an upstream 
signal that triggers p53 activation and a dO"\iVllstream 
factor that mediates apoptosis (Greenblat et aI., 1994). 
The final outcome of p53 activation depends on many 
factors. A cascade of events is triggered by the activation 
of p53 which all depend on the downstream effector genes 
that are activated by p53 (Greenblat et al.. 1994). 
After having considered the main twnour suppressor 
genes, the fllllction of these proteins can swnmarlse as 
follows: 
• They cause repression of genes that are essential for 
the continuation of the cell cycle. If these genes are 
not expressed, the cell cycle will not continue, 
effectively inhibiting cell division 
• Coupling the cell cycle to DNA diunage. As long as 
there is damaged DNA in the cell it should not divide. 
If the damage can be repaired, the cell cycle can 
continue. Loss of fllllction mutations in the genes 
encoding DNA repair enzymes promote inactivation 
of the of other twnour suppressor genes as well as 
activation of the oncogenes. If the damage C31lllot be 
repaired, the cell should initiate apoptosis or 
programmed cell death to remove the threat it poses 
to the individual 
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• Some of these proteins are involved in cell adhesion, 
preventing twnour cells from dispersing and so they 
playa very important role in inhibiting metastasis 
• Other twnour suppressor genes have been fOlllld 
to trigger senescence, others induce terminal 
differentiation and maintain genomic stability 
(Harris. 1992) 
CONCLUSION 
Research on cancer is being conducted at a very fast 
pace. Understanding the pathogenesis of neoplasia at a 
molecular, biochemical and a genetic level will be the key 
to opening doors that lead to effective treatment of this 
dreaded disease. 
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